Assembly Biosciences Cash Conversion Cycle | ASMB

Annual Cash Conversion Cycle Assembly Biosciences

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2005
2.46	0.28	25.1	-	45.7	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
45.7	0.28	18.4

Quarterly Cash Conversion Cycle Assembly Biosciences

2026-Q2	2026-Q1	2025-Q4	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	-	-	-	0.68	-	-	-	-	-	-	-	-	-	7.78	-	-	108	3.24	2.85	51.5	64.6	72.8	100	68.2	59.4	51.7	68.9	60.2	62.6	78	87.9	152	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
152	0.68	61.1

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Завод ДИОД DIOD	-32.7	-	-	-	Russia
Фармсинтез LIFE	-15.9	-	-	-	Russia
Ionis Pharmaceuticals IONS	-556	$ 43.5	0.62 %	$ 6.96 B	USA
Agios Pharmaceuticals AGIO	735	$ 31.25	0.88 %	$ 1.81 B	USA
Inhibikase Therapeutics IKT	27.9	$ 2.0	0.5 %	$ 197 M	USA
Kamada Ltd. KMDA	163	$ 8.0	1.34 %	$ 461 M	Israel
Intellia Therapeutics NTLA	48.5	$ 12.75	4.0 %	$ 1.38 B	USA
Ultragenyx Pharmaceutical RARE	75.9	$ 14.5	3.19 %	$ 1.43 B	USA
AbbVie ABBV	284	$ 265.76	1.12 %	$ 470 B	USA
AbCellera Biologics ABCL	173	$ 13.78	0.29 %	$ 4.12 B	Canada
Abeona Therapeutics ABEO	-695	$ 5.11	1.59 %	$ 271 M	USA
Arbutus Biopharma Corporation ABUS	50	$ 4.67	4.94 %	$ 895 M	Canada
ACADIA Pharmaceuticals ACAD	398	$ 20.11	0.8 %	$ 3.39 B	USA
Aclaris Therapeutics ACRS	-1.55 K	$ 4.27	0.79 %	$ 523 M	USA
Adagene ADAG	58.9	$ 2.8	0.28 %	$ 165 M	China
ADC Therapeutics SA ADCT	-543	$ 1.23	8.85 %	$ 156 M	Schweiz
ADMA Biologics ADMA	355	$ 10.11	4.01 %	$ 2.41 B	USA
Adaptive Biotechnologies Corporation ADPT	72.3	$ 29.84	5.26 %	$ 4.53 B	USA
Agenus AGEN	-25.8 K	$ 8.73	4.43 %	$ 260 M	USA
AIM ImmunoTech AIM	14.5	$ 0.19	5.56 %	$ 308 K	USA
Akebia Therapeutics AKBA	42	$ 0.91	5.26 %	$ 234 M	USA
Alector ALEC	-13.8	$ 1.99	9.94 %	$ 205 M	USA
Alkermes plc ALKS	299	$ 42.76	2.42 %	$ 7.04 B	Irlanda
Alnylam Pharmaceuticals ALNY	31.7	$ 219.89	0.08 %	$ 28.8 B	USA
Altimmune ALT	7.85 K	$ 2.67	0.36 %	$ 235 M	USA
Amgen AMGN	217	$ 402.98	0.08 %	$ 217 B	USA
Amphastar Pharmaceuticals AMPH	205	$ 25.37	0.39 %	$ 1.19 B	USA
Amarin Corporation plc AMRN	213	$ 12.09	0.31 %	$ 5.02 B	Irlanda
Amneal Pharmaceuticals AMRX	117	$ 20.35	0.25 %	$ 6.38 B	USA
AnaptysBio ANAB	205	$ 49.2	1.38 %	$ 1.43 B	USA
Anika Therapeutics ANIK	192	$ 19.73	3.3 %	$ 283 M	USA
ANI Pharmaceuticals ANIP	196	$ 72.58	0.55 %	$ 1.46 B	USA